Oramed Pharmaceuticals Stock Price on March 22, 2024

ORMP Stock  USD 2.46  0.05  1.99%   
Below is the normalized historical share price chart for Oramed Pharmaceuticals extending back to March 19, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Oramed Pharmaceuticals stands at 2.46, as last reported on the 11th of December 2024, with the highest price reaching 2.46 and the lowest price hitting 2.46 during the day.
IPO Date
21st of April 2006
200 Day MA
2.5269
50 Day MA
2.3794
Beta
1.77
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Oramed Stock, it is important to understand the factors that can impact its price. Currently, Oramed Pharmaceuticals is relatively risky. Oramed Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.0383, which implies the firm had a 0.0383% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Oramed Pharmaceuticals, which you can use to evaluate the volatility of the company. Please check Oramed Pharmaceuticals' Risk Adjusted Performance of 0.0339, coefficient of variation of 2686.86, and Semi Deviation of 2.2 to confirm if the risk estimate we provide is consistent with the expected return of 0.0953%.
  
At this time, Oramed Pharmaceuticals' Total Stockholder Equity is relatively stable compared to the past year. As of 12/11/2024, Common Stock Shares Outstanding is likely to grow to about 42.6 M, while Stock Based Compensation is likely to drop slightly above 2.2 M. . At this time, Oramed Pharmaceuticals' Price To Sales Ratio is relatively stable compared to the past year. As of 12/11/2024, Price Earnings Ratio is likely to grow to 17.70, while Price To Free Cash Flows Ratio is likely to drop (9.27). Oramed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0383

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskORMPHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 2.49
  actual daily
22
78% of assets are more volatile

Expected Return

 0.1
  actual daily
1
99% of assets have higher returns

Risk-Adjusted Return

 0.04
  actual daily
3
97% of assets perform better
Based on monthly moving average Oramed Pharmaceuticals is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oramed Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book
0.6494
Enterprise Value Ebitda
0.5244
Price Sales
141.5422
Shares Float
33.7 M
Wall Street Target Price
3.25

Oramed Pharmaceuticals Valuation on March 22, 2024

It is possible to determine the worth of Oramed Pharmaceuticals on a given historical date. On March 22, 2024 Oramed was worth 2.8 at the beginning of the trading date compared to the closed value of 2.91. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Oramed Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Oramed Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Oramed Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Oramed Pharmaceuticals' related companies.
 Open High Low Close Volume
  2.93    3.03    2.79    2.80    141,380  
03/22/2024
  2.80    2.93    2.78    2.91    68,859  
  2.89    2.89    2.71    2.76    167,630  
Backtest Oramed Pharmaceuticals  |  Oramed Pharmaceuticals History  |  Oramed Pharmaceuticals Valuation   PreviousNext  
Open Value
2.8
2.91
Closing Value
10.27
Upside

Oramed Pharmaceuticals Trading Date Momentum on March 22, 2024

On March 25 2024 Oramed Pharmaceuticals was traded for  2.76  at the closing time. The top price for the day was 2.89  and the lowest listed price was  2.71 . The trading volume for the day was 167.6 K. The trading history from March 25, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 5.15% . The trading delta at closing time against the current closing price is 1.37% .

Oramed Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Oramed Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Oramed Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Oramed financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Oramed Pharmaceuticals Stock history

Oramed Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Oramed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Oramed Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Oramed Pharmaceuticals stock prices may prove useful in developing a viable investing in Oramed Pharmaceuticals
Last ReportedProjected for Next Year
Common Stock Shares Outstanding40.6 M42.6 M

Oramed Pharmaceuticals Quarterly Net Working Capital

137.5 Million

Oramed Pharmaceuticals Stock Technical Analysis

Oramed Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Oramed Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Oramed Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Oramed Pharmaceuticals Period Price Range

Low
December 11, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Oramed Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Oramed Pharmaceuticals December 11, 2024 Market Strength

Market strength indicators help investors to evaluate how Oramed Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oramed Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Oramed Pharmaceuticals stock market strength indicators, traders can identify Oramed Pharmaceuticals entry and exit signals to maximize returns

Oramed Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Oramed Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Oramed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Oramed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Oramed Stock Analysis

When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.